Since increased stromal Foxf2 expression enhances T-cell infiltration in several prostate cancer models, we reasoned that increasing stromal Foxf2 activity can enhance the response of prostate cancer to ICIs. The gene discussed is FOXF2; the disease is prostate carcinoma.